Cargando…
Targeting Glioblastoma Stem Cells: A Review on Biomarkers, Signal Pathways and Targeted Therapy
Glioblastoma (GBM) remains the most lethal and common primary brain tumor, even after treatment with multiple therapies, such as surgical resection, chemotherapy, and radiation. Although great advances in medical development and improvements in therapeutic methods of GBM have led to a certain extens...
Autores principales: | Tang, Xuejia, Zuo, Chenghai, Fang, Pengchao, Liu, Guojing, Qiu, Yongyi, Huang, Yi, Tang, Rongrui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297686/ https://www.ncbi.nlm.nih.gov/pubmed/34307170 http://dx.doi.org/10.3389/fonc.2021.701291 |
Ejemplares similares
-
lncRNA PRADX is a Mesenchymal Glioblastoma Biomarker for Cellular Metabolism Targeted Therapy
por: Xu, Can, et al.
Publicado: (2022) -
Targeting Aggressive Cancer Stem Cells in Glioblastoma
por: Seymour, Tracy, et al.
Publicado: (2015) -
Risk Factors on the Incidence and Prognostic Effects of Colorectal Cancer With Brain Metastasis: A SEER-Based Study
por: Chen, Quan, et al.
Publicado: (2022) -
Therapeutic Targeting of Signaling Pathways Related to Cancer Stemness
por: Espinosa-Sánchez, Asunción, et al.
Publicado: (2020) -
GFAPδ: A Promising Biomarker and Therapeutic Target in Glioblastoma
por: Radu, Roxana, et al.
Publicado: (2022)